Next to our Nexus IB10 automated and portable immunoassay system we also provide customized MTP assays and testing services to fulfill the specific requirements of our customers.
Jörg Menten, previously acting as Chief Commercial Officer of the company, will focus on successfully commercializing the biomarker-based diagnostics that address high unmet needs in critical care…
SphingoTec has an international qualified network of distribution partners with which we work in close cooperation and mutual support. We are committed to providing our partners with exceptional…
In severely ill COVID-19 patients, besides the main complications that include respiratory, cardiovascular and kidney diseases, an emerging body of evidence shows that endothelial function plays a…
New evidence supporting the use of innovative biomarkers in the early identification of organ dysfunction and risk stratification of cardiac surgery patients is reported.
SphingoTec and Rivaara Labs today announced that they have entered into a multi-year distribution agreement for the commercialization of SphingoTec’s point of care diagnostic solutions in the Indian…
SphingoTec announces that its kidney function biomarker penKid is reliably identifying AKI in infants, offering a solution to the shortcomings in pediatric critical care. AKI is mostly diagnosed too…
Follow our Journey on Social Media
View all Events
View all News
Events & Expos
Latest News
Subscribe to our Newsletter
Follow the link below to subscribe to our…
